NCT01791894View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2015

Conditions
Basal Cell Carcinoma of the SkinRecurrent Skin Cancer
Interventions
DRUG

arsenic trioxide

Given IV

Trial Locations (1)

94305

Stanford University Medical Center, Stanford

All Listed Sponsors
collaborator

The V Foundation for Cancer Research

OTHER

lead

Stanford University

OTHER

NCT01791894 - Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma | Biotech Hunter | Biotech Hunter